Peptides: Tesamorelin, AOD9604, Tirzepatide (GLP-1 agonist) Tesamorelin is FDA-approved to reduce visceral adipose tissue (VAT) in HIV-associated lipodystrophy, but its fat-burning effects also appear in non-HIV populations AOD9604 is a modified fragment of human GH (176191) shown in animal and early human trials to enhance lipolysis without altering blood sugar or cortisol Tirzepatide , while technically a GLP-1/GIP agonist , is now frequently stacked with peptides in clinical practice to accelerate fat loss and appetite control
It is also non-invasive, which reduces the likelihood of complications typically associated with more aggressive treatments
For non-urgent questions, telehealth services like Doctronic.ai provide quick and affordable access to medical professionals who can help you understand your symptoms and next steps.
For more information, contact us: Thomson Specialist Skin Centre (Novena) Dr Tan Hiok Hee Dermatology (Skin) Thomson Specialist Skin Centre (Novena Specialist Center) English, Mandarin
Khi kt hp glutathione vitamin c, bn khng ch h tr chng oxy ha m cn gin tip h tr cu trc da t bn trong
Research purposes only